Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults.

Journal: Journal of clinical and translational research
Published Date: Apr 4, 2018

Abstract

BACKGROUND: Magnesium (Mg) deficiency contributes to the pathophysiology of numerous diseases. The therapeutic use of Mg has steadily increased over time. The increased in-hospital use of intravenous (IV) magnesium sulfate (MgSO4) warrants more extensive investigation regarding the safety of the therapy. The aim of this study was to determine the safety of IV MgSO4 infusion on cardiovascular, liver, kidney, and metabolic markers in adults.

Authors

  • Elisa Karhu
    Departments of Medicine.
  • Steven E Atlas
    Departments of Medicine.
  • Jinrun Gao
    Barclay's, Inc., Wilmington, DE, USA.
  • Syed A Mehdi
    Psychiatry and Behavioral Sciences.
  • Dominique Musselman
    Psychiatry and Behavioral Sciences.
  • Sharon Goldberg
    Glow Health PA, Bay Harbor Islands, FL, USA.
  • Judi M Woolger
    Departments of Medicine.
  • Raul Corredor
    Psychiatry and Behavioral Sciences.
  • Muhammad H Abbas
    Psychiatry and Behavioral Sciences.
  • Leopoldo Arosemena
    Departments of Medicine.
  • Simone Caccamo
    Departments of Medicine.
  • Ashar Farooqi
    Psychiatry and Behavioral Sciences.
  • Janet Konefal
    Family Medicine and Community Health, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Laura Lantigua
    Psychiatry and Behavioral Sciences.
  • Vanessa Padilla
    Psychiatry and Behavioral Sciences.
  • Ammar Rasul
    Psychiatry and Behavioral Sciences.
  • Eduard Tiozzo
    Psychiatry and Behavioral Sciences.
  • Oscar L Higuera
    Psychiatry and Behavioral Sciences.
  • Andrea Fiallo
    Psychiatry and Behavioral Sciences.
  • John E Lewis
    Psychiatry and Behavioral Sciences.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals